Skip to main content
Retour
Watch Compare

VOLITIONRX LTD

Qualité des données : 100%
VNRX
NYSE Manufacturing Chemicals
0,17 €
▼ 0,01 € (-3,83%)
Cap. Boursière: 27,43 M
Prix
0,17 €
Cap. Boursière
27,43 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 109,29% annually over 5 years — strong growth
Negative free cash flow of -19,77 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 69,25%
Capital efficient — spends only 5,18% of revenue on capex

Croissance

Revenue Growth (5Y)
109,29%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)40,04%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-1352,16%
Op. Margin-1258,47%

Sécurité

Debt / Equity
N/A
Current Ratio0,12
Interest CoverageN/A

Valorisation

PE (TTM|2027)
-1,17 | 0,71
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -1,2 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % -1352,2 -41,5
Rev Growth 5Y % 109,3 1,8
D/E — 0,3

Objectif de Cours des Analystes

5 analystes
Buy
Actuel
0,17 €
+1082.1%
Objectif
1,96 €
1,00 €
1,80 €
3,00 €
Prévisions
P/E Prévisionnel 0,69
BPA Prévisionnel 0,24 €
CA Est. 50,12 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 0,24 €
-0,06 € – 0,54 €
 50,12 M 2
FY2026 -0,12 €
-0,15 € – -0,11 €
 2,32 M 3

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,04 € -0,05 € -13,5%
Q32025 -0,05 € -0,05 € -1,6%
Q22025 -0,05 € -0,07 € -30,6%
Q12025 -0,05 € -0,06 € -33,3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 40,04% Revenue Growth (3Y) 49,27%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 109,29% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,73 M Net Income (TTM) -23,36 M
ROE N/A ROA -308,27%
Gross Margin N/A Operating Margin -1258,47%
Net Margin -1352,16% Free Cash Flow (TTM) -19,77 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,12
Interest Coverage N/A Asset Turnover 0,23
Working Capital -10,09 M Tangible Book Value -34,94 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,17 Forward P/E N/A
P/B Ratio N/A P/S Ratio 15,88
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -72,08%
Market Cap 27,43 M Enterprise Value 33,71 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,01
FCF / Share -0,12 OCF / Share -0,12
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 5,18% FCF Conversion 84,66%
SBC-Adj. FCF -21,35 M Growth Momentum -69,25

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,73 M 1,23 M 775 302,0 306 392,0 90 035,0
Net Income -23,36 M -27,26 M -35,68 M -30,60 M 137,00 M
EPS (Diluted) — -0,31 — — —
Gross Profit — — — — —
Operating Income -21,74 M -27,02 M -35,99 M -31,78 M -28,33 M
EBITDA — — — — —
R&D Expenses 10,08 M 14,41 M 19,55 M 14,57 M 15,54 M
SG&A Expenses — — — — —
D&A 983 706,0 1,11 M 1,15 M 936 084,0 945 367,0
Interest Expense — — — — 155 803,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6,90 M 9,40 M 27,95 M 18,30 M 27,49 M
Total Liabilities 42,49 M 35,51 M 36,66 M 21,42 M 9,77 M
Shareholders' Equity -34,25 M -24,91 M -7,80 M -3,13 M 17,72 M
Total Debt 6,71 M 4,81 M 4,83 M 3,85 M 3,07 M
Cash & Equivalents 1,12 M 3,26 M 20,73 M 10,87 M 20,58 M
Current Assets 2,06 M 4,06 M 21,85 M 12,17 M 21,98 M
Current Liabilities 12,23 M 7,79 M 31,84 M 17,39 M 6,52 M